Business Segments · Goodwill
Cardiovascular — Goodwill
Boston Scientific Cardiovascular — Goodwill decreased by 0.1% to $10.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $9.84B to $10.56B. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Goodwill shows an upward trend with a 13.7% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ1 2026May 1, 2026
Rolls up toGoodwill
How to read this metric
An increase suggests recent acquisitions in the cardiovascular space, while a decrease may indicate impairment charges.
Detailed definition
Represents the total carrying value of goodwill specifically attributed to the Cardiovascular business segment. This ass...
Peer comparison
Commonly reported by medical device peers like Medtronic or Abbott under segment-level intangible assets.
Metric ID:
bsx_segment_cardiovascular_goodwillHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.7B | $5.68B | $7.74B | $8.71B | $8.64B | $8.62B | $8.68B | $9.03B | $9.05B | $9B | $9.04B | $9.02B | $9.06B | $9.68B | $9.61B | $9.84B | $10.55B | $10.53B | $10.57B | $10.56B |
| QoQ Change | — | -0.3% | +36.2% | +12.5% | -0.7% | -0.2% | +0.7% | +4.0% | +0.2% | -0.6% | +0.5% | -0.2% | +0.4% | +6.9% | -0.8% | +2.4% | +7.2% | -0.2% | +0.4% | -0.1% |
| YoY Change | — | — | — | — | +51.7% | +51.8% | +12.2% | +3.8% | +4.7% | +4.3% | +4.1% | -0.1% | +0.1% | +7.6% | +6.2% | +9.1% | +16.5% | +8.7% | +10.1% | +7.3% |
Range$5.68B – $10.57B
CAGR+13.9%
Avg YoY Growth+12.4%
Median YoY Growth+7.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — goodwill?
- Boston Scientific (BSX) reported cardiovascular — goodwill of $10.56B in Q1 2026.
- How has Boston Scientific's cardiovascular — goodwill changed year-over-year?
- Boston Scientific's cardiovascular — goodwill increased by 7.3% year-over-year, from $9.84B to $10.56B.
- What is the long-term trend for Boston Scientific's cardiovascular — goodwill?
- Over 4 years (2021 to 2025), Boston Scientific's cardiovascular — goodwill has grown at a 13.7% compound annual growth rate (CAGR), from $24.82B to $41.49B.
- What does cardiovascular — goodwill mean?
- The total value of goodwill recorded for the Cardiovascular business unit.